PCM
IBB icon

Ping Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Ping Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,000
Closed -$338K – 90
2025
Q4 		$338K Sell
2,000
-6,000
-75% -$975K 0.1% 59
2025
Q3 		$1.15M Hold
8,000
– – 0.39% 37
2025
Q2 		$1.01M Buy
8,000
+1,000
+14% +$123K 0.25% 43
2025
Q1 		$895K Hold
7,000
– – 0.33% 41
2024
Q4 		$925K Buy
7,000
+2,500
+56% +$351K 0.22% 39
2024
Q3 		$655K Hold
4,500
– – 0.18% 46
2024
Q2 		$618K Buy
+4,500
New +$601K 0.19% 43

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ping Capital Management's IBB Position: Q1 2026 in Review

Ping Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 2,000 shares — an estimated $338K sold.

Ping Capital Management first reported a position in IBB in Q2 2024 and held it in 7 quarters. The position peaked at $1.15M in Q3 2025. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Ping Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Ping Capital Management sold 2,000 iShares Biotechnology ETF shares in Q1 2026, an estimated $338K.
  • Ping Capital Management first reported a position in iShares Biotechnology ETF in Q2 2024 and held it in 7 quarters.
  • Ping Capital Management's iShares Biotechnology ETF position peaked at $1.15M in Q3 2025.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Ping Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.